Literature DB >> 2875149

Non-ionic surfactant vesicles, niosomes, as a delivery system for the anti-leishmanial drug, sodium stibogluconate.

A J Baillie, G H Coombs, T F Dolan, J Laurie.   

Abstract

Liver and serum concentrations of antimony in the mouse have been determined after administration of sodium stibogluconate in the free, liposomal and niosomal form. High liver and low serum values were attained by the use of both vesicular formulations. Niosomal sodium stibogluconate was shown to be more active than free drug against experimental murine visceral leishmaniasis, an effect apparently dependent on maintaining high drug levels in the infected reticuloendothelial system.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2875149     DOI： 10.1111/j.2042-7158.1986.tb04623.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN： 0022-3573            Impact factor:   3.765


  12 in total

1.  Reduced tissue parasitic load and infectivity to sand flies in dogs naturally infected by Leishmania (Leishmania) chagasi following treatment with a liposome formulation of meglumine antimoniate.

Authors:  Raul R Ribeiro; Eliane P Moura; Vitor M Pimentel; Weverton M Sampaio; Sydnei M Silva; Dante A Schettini; Cintia F Alves; Ferdinan A Melo; Wagner L Tafuri; Cynthia Demicheli; Maria N Melo; Frédéric Frézard; Marilene S M Michalick
Journal:  Antimicrob Agents Chemother       Date:  2008-05-05       Impact factor: 5.191

2.  Inhibition of hepatitis C virus replication by antimonial compounds.

Authors:  Der-Ren Hwang; Ren-Kuo Lin; Guang-Zhou Leu; Tiao-Yin Lin; Tzu-Wen Lien; Ming-Chen Yu; Chau-Ting Yeh; John T-A Hsu
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

Review 3.  Niosomes: a novel targeted drug delivery system for cancer.

Authors:  Maryam Moghtaderi; Kamand Sedaghatnia; Mahsa Bourbour; Mahdi Fatemizadeh; Zahra Salehi Moghaddam; Faranak Hejabi; Fatemeh Heidari; Sameer Quazi; Bahareh Farasati Far
Journal:  Med Oncol       Date:  2022-09-29       Impact factor: 3.738

4.  New sterically stabilized vesicles based on nonionic surfactant, cholesterol, and poly(ethylene glycol)-cholesterol conjugates.

Authors:  S Beugin; K Edwards; G Karlsson; M Ollivon; S Lesieur
Journal:  Biophys J       Date:  1998-06       Impact factor: 4.033

5.  Therapy with sodium stibogluconate in stearylamine-bearing liposomes confers cure against SSG-resistant Leishmania donovani in BALB/c mice.

Authors:  Jayeeta Roychoudhury; Roma Sinha; Nahid Ali
Journal:  PLoS One       Date:  2011-03-10       Impact factor: 3.240

6.  Niosome: A future of targeted drug delivery systems.

Authors:  Karim Masud Kazi; Asim Sattwa Mandal; Nikhil Biswas; Arijit Guha; Sugata Chatterjee; Mamata Behera; Ketousetuo Kuotsu
Journal:  J Adv Pharm Technol Res       Date:  2010-10

Review 7.  Nanostructured delivery systems with improved leishmanicidal activity: a critical review.

Authors:  Natascia Bruni; Barbara Stella; Leonardo Giraudo; Carlo Della Pepa; Daniela Gastaldi; Franco Dosio
Journal:  Int J Nanomedicine       Date:  2017-07-26

Review 8.  Nonionic surfactant vesicles in ocular delivery: innovative approaches and perspectives.

Authors:  Ranjan Ku Sahoo; Nikhil Biswas; Arijit Guha; Nityananda Sahoo; Ketousetuo Kuotsu
Journal:  Biomed Res Int       Date:  2014-06-03       Impact factor: 3.411

9.  Sodium stibogluconate loaded nano-deformable liposomes for topical treatment of leishmaniasis: macrophage as a target cell.

Authors:  M Junaid Dar; Fakhar Ud Din; Gul Majid Khan
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

10.  First example of a lipophilic porphyrin-cardanol hybrid embedded in a cardanol-based micellar nanodispersion.

Authors:  Ermelinda Bloise; Luigi Carbone; Giuseppe Colafemmina; Lucia D'Accolti; Selma Elaine Mazzetto; Giuseppe Vasapollo; Giuseppe Mele
Journal:  Molecules       Date:  2012-10-18       Impact factor: 4.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.